Ethambutol/isoniazid/rifampicin
| Combination of | |
|---|---|
| ethambutol | anti-tuberculosis medication |
| isoniazid | anti-tuberculosis medication |
| rifampicin | anti-tuberculosis medication |
| Clinical data | |
| ATC code | |
| Identifiers | |
| ChemSpider |
|
Ethambutol/isoniazid/rifampicin, also known as ethambutol/isoniazid/rifampin, is a fixed-dose combination medication used to treat tuberculosis.[1] It contains ethambutol, isoniazid, and rifampicin.[1] It is used either along or with other anti-tuberculosis medication.[1] It is taken by mouth.[1] Side effects are those of the underlying medications.[1] Use may not be suitable in children.[1]
It is on the World Health Organization's List of Essential Medicines.[2]
See also
References
- ^ a b c d e f World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. p. 142. hdl:10665/44053. ISBN 9789241547659.
- ^ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
Further reading
- World Health Organization (February 2008). Rifampicin, Isoniazid, and Ethambutol hydrochloride (PDF) (Report). World Health Organization. QAS/07.220/FINAL.
External links
- "Ethambutol". Drug Information Portal. U.S. National Library of Medicine.
- "Isoniazid". Drug Information Portal. U.S. National Library of Medicine.
- "Rifampin". Drug Information Portal. U.S. National Library of Medicine.
 | This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |